It acts on three receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Methods Animal studies All experiments were performed under the UK Home Office project licence PE50F6065 in accordance with the UK Animals (Scientific Procedures) Act, 1986, and approved by the University of Cambridge Animal Welfare and Ethical Review Body
For a more detailed tirzepatide comparison, the retatrutide versus tirzepatide dosage chart lays out the differences in dosing approaches
The authors observed that "early-stage disease may represent an optimal treatment window for maximizing therapeutic effects," while stressing that the concept requires validation in prospective trials designed specifically for that population
Aromatase inhibitors, a common class of breast cancer medication, seem to limit the effectiveness of GLP-1 drugs, perhaps due to their anti-estrogen effects
Trials are expanding data on the benefits of GLP-1s in chronic kidney disease and heart failure with preserved ejection fraction (HFpEF)